Trial Profile
An open-label prospective trial to evaluate functional outcomes of OROS methylphenidate in children with ADHD (FOSCO)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2014
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms FOSCO
- Sponsors Janssen
- 19 Nov 2009 New trial record